AbbVie Buy or Sell Recommendation

Macroaxis provides AbbVie Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AbbVie buy-and-hold prospective. Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Symbol
Execute Advice
AbbVie Inc -- USA Stock  

USD 104.36  0.28  0.27%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AbbVie Inc is 'Cautious Hold'.
For the selected time horizon AbbVie Inc has a mean deviation of 0.8715, semi deviation of 0.4781, standard deviation of 1.05, variance of 1.09, downside variance of 0.6142 and semi variance of 0.2285
Macroaxis provides buy, hold, or sell suggestion on AbbVie Inc to complement and cross-verify current analyst consensus on AbbVie Inc. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure AbbVie is not overpriced, please confirm all AbbVie Inc fundamentals including its Shares Outstanding, Net Income, Price to Earnings To Growth, as well as the relationship between Price to Book and Current Ratio . Given that AbbVie Inc has Price to Earning of 24.37 times, we suggest you validate AbbVie Inc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.29Value At Risk1.1
Potential Upside1.82Standard Deviation1.05
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Schwab Charles Investment Management IncCommon Shares5.9 M567.5 M
Bank Of MontrealCommon Shares5.4 M522.7 M
National Pension ServiceCommon Shares1.3 M123.6 M
Gateway Investment Advisers LlcCommon Shares882.5 K85.3 M
Nisa Investment Advisors LlcCommon Shares551.7 K53.4 M
Gulf International Bank Uk LtdCommon Shares504.5 K48.8 M
Rnc Capital Management LlcCommon Shares467.2 K45.2 M

AbbVie Greeks

α
Alpha over DOW
=0.35
β
Beta against DOW=0.28
σ
Overall volatility
=1.1
Ir
Information ratio =0.0463

AbbVie Volatility Alert

AbbVie Inc exhibits relatively low volatility with skewness of 0.26 and kurtosis of -0.89. However, we advice investors to further investigate AbbVie Inc to make sure all market statistics is disseminated and is consistent with investors' estimations about AbbVie upside potential.
    
 Better Than Average     
    
 Worse Than Average Compare AbbVie to competition
FundamentalsAbbViePeer Average
Return On Equity101.06 % (15.17) %
Return On Asset9.64 % (15.64) %
Profit Margin24.38 % (5.5) %
Operating Margin38.31 % (10.91) %
Current Valuation188.72 B152.14 B
Shares Outstanding1.6 B1.43 B
Shares Owned by Insiders0.07 % 6.91 %
Shares Owned by Institutions73.74 % 18.37 %
Number of Shares Shorted15.15 M3.24 M
Price to Earning24.37 times40.69 times
Price to Book23.95 times14.44 times
Price to Sales5.87 times17.81 times
Revenue27.27 B9.85 B
Gross Profit19.8 B21.75 B
EBITDA11.91 B1.41 B
Net Income6.62 B517.71 M
Cash and Equivalents9.55 B3.89 B
Cash per Share5.99 times5.17 times
Total Debt38.09 B7.36 B
Debt to Equity569.6 % 0.72 %
Current Ratio1.45 times3.3 times
Book Value Per Share4.19 times13.64 times
Cash Flow from Operations8.92 B1.25 B
Short Ratio2.3 times2.09 times
Earnings Per Share4.12 times2.3 times
Price to Earnings To Growth1.2 times1.22 times
Number of Employees28 K10.67 K
Beta1.390.34
Market Capitalization160.19 B29.78 B
Total Asset53.05 B126.86 B
Retained Earnings4.38 B38.24 B
Working Capital5.42 B3.58 B
Current Asset16.31 B36.8 B
SellBuy
Cautious Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Sale by Richard Gonzalez of 500 shares of AbbVie [view details]
Risk Adjusted Performance0.1321
Market Risk Adjusted Performance(1.02)
Mean Deviation0.8715
Semi Deviation0.4781
Downside Deviation0.7837
Coefficient Of Variation354.64
Standard Deviation1.05
Variance1.09
Information Ratio0.0463
Jensen Alpha0.3501
Total Risk Alpha(0.27)
Sortino Ratio0.0617
Treynor Ratio(1.03)
Maximum Drawdown3.36
Value At Risk(1.1)
Potential Upside1.82
Downside Variance0.6142
Semi Variance0.2285
Expected Short fall(1.17)
Skewness0.2594
Kurtosis(0.89)

Current Valuation

AbbVie Current Valuation Analysis
AbbVie Inc is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceuticals And Biosciences industry is presently estimated at about 442.88 Billion. AbbVie totals roughly 188.72 Billion in current valuation claiming about 43% of equities listed under Pharmaceuticals And Biosciences industry.